M&A Deal Summary

Integer Acquires Aran Biomedical

On April 7, 2022, Integer acquired medical products company Aran Biomedical for 120M EUR

Acquisition Highlights
  • This is Integer’s 10th transaction in the Medical Products sector.
  • This is Integer’s 3rd largest (disclosed) transaction.
  • This is Integer’s 1st transaction in Ireland.

M&A Deal Summary
Date 2022-04-07
Target Aran Biomedical
Sector Medical Products
Buyer(s) Integer
Deal Type Add-on Acquisition
Deal Value 120M EUR

Target

Aran Biomedical

Galway, Ireland
website
Aran Biomedical offers expert design, development, and manufacturing solutions for implantable medical devices. Aran Biomedical's technology portfolio and expertise deliver solutions that reduce profile and improve device performance. Aran Biomedical partners with medical device OEMs globally, enabling companies to supply next-generation products to clinicians and their patients. Aran Biomedical was founded in 2002 and is based in Galway, Ireland.

Search 192,611 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Integer

Plano, Texas, United States

website

Category Company
Founded 1970
Sector Medical Products
Employees10,000
Revenue 1.4B USD (2022)
DESCRIPTION

Integer is one of the largest medical device outsource (MDO) manufacturers in the world serving the cardiac, neuromodulation, orthopedics, vascular, advanced surgical and power solutions markets. Integer offers a breadth and depth of design, development and manufacturing capabilities unmatched by anyone. Our keen focus on quality meets the strictest standards. With approximately 10,000 associates, including 600 engineers, and 26 manufacturing facilities in seven countries, we are proud of the role we play in enabling our customers to deliver innovative medical technologies that enhance people’s lives. Integer was founded in 1970 and is based in Plano, Texas.

DEAL STATS #
Overall 12 of 13
Sector (Medical Products) 10 of 11
Type (Add-on Acquisition) 12 of 13
Country (Ireland) 1 of 1
Year (2022) 1 of 1
Size (of disclosed) 3 of 9
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-12-02 Oscor

Palm Harbor, Florida, United States

Oscor designs, develops, manufactures, and markets a variety of highly specialized implantable cardiac pacing and neurostimulation leads, venous access systems, and diagnostic catheters, serving the cardiovascular and neurostimulation markets. Oscor was founded in 1982 and is based in Palm Harbor, Florida.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2024-01-10 Pulse Technologies

Quakertown, Pennsylvania, United States

Pulse Technologies is a privately-held technology, engineering, and contract manufacturing company focused on complex micromachining of medical device components for high-growth structural heart, heart pump, electrophysiology, leadless pacing, and neuromodulation markets. The company also provides proprietary advanced technologies, including Hierarchical Surface Restructuring (HSR), Scratch-Free Surface Finishes, and Titanium Nitride Coatings. Pulse Technologies is based in Quakertown, Pennsylvania.

Buy $140M
Mergr

Product

Company

Legal